SECOND PRIMARY MALIGNANCIES IN T1-3N0 PROSTATE CANCER PATIENTS TREATED WITH RADIATION THERAPY WITH 10-YEAR FOLLOWUP

1998 ◽  
Vol 159 (3) ◽  
pp. 946-949 ◽  
Author(s):  
PETER A.S. JOHNSTONE ◽  
CURT R. POWELL ◽  
ROBERT RIFFENBURGH ◽  
DAVID C. ROHDE ◽  
CHRISTOPHER J. KANE
1998 ◽  
pp. 946-949 ◽  
Author(s):  
PETER A. S. JOHNSTONE ◽  
CURT R. POWELL ◽  
ROBERT RIFFENBURGH ◽  
DAVID C. ROHDE ◽  
CHRISTOPHER J. KANE

2022 ◽  
Author(s):  
Yijun Wu ◽  
Yunlong Li ◽  
Chang Han ◽  
Yuming Chong ◽  
Kai Kang ◽  
...  

Background: The effect of radiotherapy (RT) for second primary malignancies (SPMs) among prostate cancer survivors is controversial. Methods: Applying logistic regression, competing risk analysis and propensity score matching method, this study analyzed clinical data from the Surveillance, Epidemiology, and End Results program to compare the risk for SPMs between patients receiving RT and non-RT. Results: In this study, prostate cancer patients treated with RT developed more SPMs in the anus, bladder, rectum, liver, lung and bronchus and lymphoma than non-RT groups. Conclusion: More intensive surveillance should be adopted for these cancers among prostate cancer survivors.


2000 ◽  
Vol 36 (1) ◽  
pp. 100-105 ◽  
Author(s):  
K. Bergfeldt ◽  
C. Silfverswärd ◽  
S. Einhorn ◽  
P. Hall

Sign in / Sign up

Export Citation Format

Share Document